number and rate per 100 000 population EU EEA 20102014 Source Country reports Legend Y yes N no C case based no report ASR agestandardised rate Suggested citation European Centre for Disease Prevention and Control Annual epidemiological report ID: 759633
Download Presentation The PPT/PDF document "Table 1. Cases of reported, confirmed c..." is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Slide1
Table 1. Cases of reported, confirmed cases of invasive pneumococcal disease: number and rate per 100 000 population, EU/EEA, 2010–2014
Source: Country reports. Legend: Y = yes, N = no, C = case based, · = no report, ASR: age-standardised rateSuggested citation: European Centre for Disease Prevention and Control. Annual epidemiological report 2015. Invasive pneumococcal disease. Stockholm: ECDC; 2016. © European Centre for Disease Prevention and Control, 2016. Reproduction is authorised, provided the source is acknowledged
Country
2010
2011
2012
2013
2014
Cases
Rate
Cases
Rate
Cases
Rate
Cases
Rate
National data
Report type
Reported cases
Confirmed cases
Rate
ASR
Austria
325
3.9
158
1.9
234
2.8
350
4.1
Y
C
322
322
3.8
3.5
Belgium
1851
-
1836
-
1738
-
1604
-
N
C
1192
1192
-
-
Bulgaria
26
0.4
37
0.5
19
0.3
17
0.2
Y
A
21
21
0.3
0.3
Croatia
.
.
.
.
18
0.4
16
0.4
Y
A
27
27
0.6
0.2
Cyprus
12
1.5
15
1.8
19
2.2
8
0.9
Y
C
14
14
1.6
1.7
Czech Republic
300
2.9
384
3.7
335
3.2
424
4.0
Y
C
337
337
3.2
3.1
Denmark
960
17.3
924
16.6
882
15.8
842
15.0
Y
C
725
725
12.9
12.1
Estonia
14
1.1
18
1.4
20
1.5
24
1.8
Y
C
12
12
0.9
0.9
Finland
834
15.6
779
14.5
752
13.9
724
13.3
Y
C
703
703
12.9
12.0
France
5117
10.5
5037
10.4
4430
9.0
3687
7.6
74%
C
3184
3184
6.5
6.2
Germany
.
.
.
.
.
.
.
.
.
.
.
.
.
.
Greece
38
0.3
41
0.4
43
0.4
40
0.4
Y
C
30
30
0.3
0.3
Hungary
108
1.1
107
1.1
186
1.9
202
2.0
Y
C
150
150
1.5
1.5
Iceland
32
10.1
33
10.4
27
8.4
19
5.9
Y
C
24
24
7.4
8.8
Ireland
304
6.7
357
7.8
350
7.6
347
7.6
Y
C
342
342
7.4
8.3
Italy
854
1.4
713
1.2
814
1.4
977
1.6
Y
C
957
957
1.6
1.4
Latvia
16
0.8
51
2.5
56
2.7
56
2.8
Y
C
51
51
2.5
2.4
Liechtenstein
.
.
.
.
.
.
.
.
.
.
.
.
.
.
Lithuania
9
0.3
9
0.3
7
0.2
17
0.6
Y
C
7
6
0.2
0.2
Luxembourg
2
0.4
2
0.4
1
0.2
1
0.2
Y
C
1
1
0.2
0.2
Malta
11
2.7
11
2.7
15
3.6
6
1.4
Y
C
22
22
5.2
4.9
Netherlands
571
13.8
622
14.9
635
15.2
652
15.5
25%
C
550
546
13.0
12.4
Norway
748
15.4
729
14.8
626
12.6
620
12.3
Y
C
569
569
11.1
11.3
Poland
333
0.9
351
0.9
441
1.2
540
1.4
Y
C
705
705
1.9
1.9
Portugal
.
.
.
.
.
.
.
.
.
.
.
.
.
.
Romania
80
0.4
90
0.4
79
0.4
92
0.5
Y
C
62
62
0.3
0.3
Slovakia
18
0.3
57
1.1
49
0.9
84
1.6
Y
C
78
78
1.4
1.5
Slovenia
224
10.9
255
12.4
245
11.9
278
13.5
Y
C
276
276
13.4
12.8
Spain
2212
5.9
2220
5.9
2260
6.0
2026
5.4
80%
C
1856
1856
5.0
4.7
Sweden
1456
15.6
1361
14.5
1387
14.6
1316
13.8
Y
C
1159
1159
12.0
11.0
United Kingdom
5616
9.0
4631
7.3
5208
8.2
5045
7.9
Y
C
4157
4157
6.5
6.3
EU/EEA
22071
6.0
20828
5.7
20876
5.7
20014
5.4
.
C
17533
17528
4.8
4.6
Slide2Figure 1. Reported, confirmed cases of invasive pneumococcal disease, EU/EEA, 2014
Source: Country reports from Austria, Belgium, Bulgaria, Croatia, Cyprus, the Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, the Netherlands, Norway, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden, the United Kingdom.Suggested citation: European Centre for Disease Prevention and Control. Annual epidemiological report 2015. Invasive pneumococcal disease. Stockholm: ECDC; 2016. © European Centre for Disease Prevention and Control, 2016. Reproduction is authorised, provided the source is acknowledged
Slide3Figure 2. Number of reported, confirmed cases of invasive pneumococcal disease per 100 000 population, EU/EEA, 2014
Source: Country reports from: Austria, Bulgaria, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, the Netherlands, Norway, Poland, Romania, Slovakia, Slovenia, Spain, Sweden, the United Kingdom. Suggested citation: European Centre for Disease Prevention and Control. Annual epidemiological report 2015. Invasive pneumococcal disease. Stockholm: ECDC; 2016. © European Centre for Disease Prevention and Control, 2016. Reproduction is authorised, provided the source is acknowledged
Slide4Figure 3. Cases of reported, confirmed invasive pneumococcal disease, by age and gender, EU/EEA, 2014
Source: Country reports from: Austria, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, the Netherlands, Norway, Poland, Romania, Slovakia, Slovenia, Spain, Sweden, the United Kingdom. Suggested citation: European Centre for Disease Prevention and Control. Annual epidemiological report 2015. Invasive pneumococcal disease. Stockholm: ECDC; 2016. © European Centre for Disease Prevention and Control, 2016. Reproduction is authorised, provided the source is acknowledged
Slide5Figure 4. Seasonal distribution of reported, confirmed cases of invasive pneumococcal disease, EU/EEA, 2014 compared with 2010−2013
Source: Country reports from: Austria, Belgium, Cyprus, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, the Netherlands, Norway, Poland, Romania, Slovakia, Slovenia, Spain, Sweden, the United Kingdom.Suggested citation: European Centre for Disease Prevention and Control. Annual epidemiological report 2015. Invasive pneumococcal disease. Stockholm: ECDC; 2016. © European Centre for Disease Prevention and Control, 2016. Reproduction is authorised, provided the source is acknowledged
Slide6Figure 5. Trend and number of reported, confirmed cases of invasive pneumococcal disease, EU/EEA, 2010−2014
Source: Country reports from Austria, Belgium, Cyprus, the Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Malta, the Netherlands, Norway, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden, the United Kingdom.Suggested citation: European Centre for Disease Prevention and Control. Annual epidemiological report 2015. Invasive pneumococcal disease. Stockholm: ECDC; 2016. © European Centre for Disease Prevention and Control, 2016. Reproduction is authorised, provided the source is acknowledged
Slide7Figure 6. Distribution of confirmed cases of invasive pneumococcal disease: most common serotypes in 2014 (n=12 980), 2013 (n=14 811) and 2012 (n=14 845)
* Covered by PCV7, PCV10, PCV13 and PPV23~ Covered by PCV10, PCV13 and PPV23† Covered by PCV13 and PPV23˄ Covered by PPV23Source: Country reports from: Austria, Belgium, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Malta, Netherlands, Norway, Poland, Romania, Slovakia, Slovenia, Spain, Sweden, United Kingdom.Suggested citation: European Centre for Disease Prevention and Control. Annual epidemiological report 2015. Invasive pneumococcal disease. Stockholm: ECDC; 2016. © European Centre for Disease Prevention and Control, 2016. Reproduction is authorised, provided the source is acknowledged
Slide8Figure 7. Invasive pneumococcal disease, reported confirmed cases aged <5 years: serotype distribution by PCV vaccine type, 2011–2014 (n= 4 783)
* Although serotype 6A is included in PCV13 and not in PCV7, it is considered to be a PCV7 serotype in the analysis due to documented cross-protection provided by the serotype 6B antigen in PCV7. PCV7 serotypes: 4, 6A, 6B, 9V, 14, 18C, 19F, 23F; PCV10non7 serotypes: 1, 5, 7F; PCV13non10 serotypes: 3, 19A; Non-PCV serotypes: all remaining serotypes.Suggested citation: European Centre for Disease Prevention and Control. Annual epidemiological report 2015. Invasive pneumococcal disease. Stockholm: ECDC; 2016. © European Centre for Disease Prevention and Control, 2016. Reproduction is authorised, provided the source is acknowledged
Slide9Figure 8. Susceptibility of confirmed cases of invasive pneumococcal disease to cefotaxime/ceftriaxone, penicillin and erythromycin, 2012–2014
Source: For penicillin, country reports from: Austria, Belgium, Cyprus (2012), Denmark, Estonia, Finland, France, Hungary, Iceland (2012, 2014), Ireland, Italy, Latvia (2013, 2014), Lithuania (2012, 2013), Norway, Poland, Romania (2013), Slovakia, Slovenia, Spain, United Kingdom (2012, 2013, 2014). Total number of cases – 2012: n=12 226; 2013: n=11 493; 2014: n=9 283.For erythromycin, country reports from: Austria, Cyprus (2013, 2014), Denmark, Estonia, Finland, France, Hungary, Iceland (2012, 2014), Ireland, Italy, Latvia (2013, 2014), Lithuania (2012, 2013), Norway, Poland, Romania (2013), Slovakia, Slovenia, Spain, United Kingdom (2012, 2013, 2014). Total number of cases – 2012: n=9 685; 2013: n=9 202; 2014: n=7 548.For cefotaxime/ceftriaxone, country reports from: Austria (2012, 2013), Cyprus (2012), Denmark, Estonia, Finland (2012, 2014), France (2012), Hungary, Iceland (2012, 2014), Ireland, Latvia (2013, 2014), Lithuania (2012, 2013), Norway, Poland, Romania (2013), Slovakia, Slovenia, Spain, United Kingdom (2012, 2013, 2014). Total number of cases – 2012: n=6 419; 2013: n=4 715; 2014: n=4 592.Note: SIR values (susceptible, intermediate, and resistant) are displayed as interpreted by the reporting countries. ‘Intermediate’ and ‘resistant’ were categorised as ‘non-susceptible’. Suggested citation: European Centre for Disease Prevention and Control. Annual epidemiological report 2015. Invasive pneumococcal disease. Stockholm: ECDC; 2016. © European Centre for Disease Prevention and Control, 2016. Reproduction is authorised, provided the source is acknowledged
Slide10Table. Invasive pneumococcal disease, surveillance systems overview, 2014
Surveillance characteristics: compulsory (Cp), comprehensive (co), voluntary (V), other (O), active (A), passive (P), case-based (C), aggregated (A)Data reported by: laboratories (L), physicians (P), hospitals (H), other (O)Suggested citation: European Centre for Disease Prevention and Control. Annual epidemiological report 2016. Invasive pneumococcal disease. Stockholm: ECDC; 2016. © European Centre for Disease Prevention and Control, 2016. Reproduction is authorised, provided the source is acknowledged
Surveillance
Data reported by
Case definition used
characteristics
Country
Data source
L
P
H
O
Austria
AT-Epidemiegesetz
Cp
Co
P
C
Y
Y
Y
Y
EU-2008
Belgium
BE-REFLAB
V
Se
A
C
Y
N
N
N
EU-2008
Bulgaria
BG-NATIONAL_SURVEILLANCE
Cp
Co
P
A
Y
Y
Y
Y
EU-2008
Croatia
HR-CNIPH
Cp
Co
P
A
Y
Y
Y
Y
EU-2012
Cyprus
CY-NOTIFIED_DISEASES
Cp
Co
P
C
N
Y
N
N
EU-2008
Czech Republic
CZ-NRL-STR
Cp
Co
A
C
Y
Y
Y
N
EU-2008
Denmark
DK-LAB
Cp
Co
P
C
Y
N
N
N
Not specified/unknown
Estonia
EE-NAKIS
Cp
Co
P
C
Y
Y
Y
N
EU-2012
Finland
FI-NIDR
Cp
Co
P
C
Y
N
N
N
Not specified/unknown
France
FR-EPIBAC
V
Se
A
C
Y
N
Y
N
EU-2008
Greece
EL-Notification/Laboratory data
Cp
Co
P
C
Y
Y
Y
Y
EU-2008
Hungary
HU-NRL_PNEU
V
Co
P
C
Y
N
N
N
EU-2008
Iceland
IS-SUBJECT_TO_REGISTRATION
Cp
Co
P
C
Y
Y
Y
N
EU-2012
Ireland
IE-PNEU
Cp
Co
P
C
Y
Y
Y
N
EU-2008
Italy
IT-MENINGITIS
V
Co
P
C
N
Y
Y
N
EU-2012
Latvia
LV-BSN
Cp
Co
P
C
Y
Y
Y
Y
EU-2012
Lithuania
LT-COMMUNICABLE_DISEASES
Cp
Co
P
C
Y
Y
N
N
EU-2008
Luxembourg
LU-SYSTEM1
Cp
Co
P
C
N
Y
N
N
EU-2002
Malta
MT-DISEASE_SURVEILLANCE
Cp
Co
P
C
Y
Y
Y
Y
EU-2008
Netherlands
NL-NRBM
V
Se
P
C
Y
N
N
N
EU-2008
Norway
NO-MSIS_A
Cp
Co
P
C
Y
Y
Y
N
EU-2012
Poland
PL-NATIONAL_SURVEILLANCE
Cp
Co
P
C
Y
Y
Y
N
EU-2008
Romania
RO-RNSSy
Cp
Co
P
C
N
N
Y
N
EU-2008
Slovakia
SK-EPIS
Cp
Co
A
C
Y
Y
Y
N
EU-2012
Slovenia
SI-SURVIVAL
Cp
Co
P
C
Y
Y
Y
N
EU-2008
Spain
ES-NRL
V
O
P
C
Y
N
Y
N
Not specified/unknown
Sweden
SE-SMINET
Cp
Co
P
C
Y
Y
Y
N
EU-2012
United Kingdom
UK-PNEUMOCOCCAL
O
Co
P
C
Y
N
Y
Y
EU-2012